Phase III Atlantis is a Clinical Study that tries to get the Efficacy of a Combination of Lurbinectedin plus Doxorubicin in Patients wil Small-Cell Lung Cancer.
The Renowned Oncologist Dr. Paz Ares tell us about it, saying that the main objective of this study is to improve the progression free-survival (PFS) of those patients, to provice some new hope and better quality of life to our patients.